Drug treatment of obsessive-compulsive disorder

M Kellner - Dialogues in clinical neuroscience, 2010 - Taylor & Francis
Knowledge of pharmacotherapeutic treatment options in obsessive-compulsive disorder
(OCD) has grown considerably over the past 40 years. Serotonergic antidepressants, such …

Augmentation of cognitive and behavioural therapies (CBT) with d‐cycloserine for anxiety and related disorders

R Ori, T Amos, H Bergman… - Cochrane Database …, 2015 - cochranelibrary.com
Background A significant number of patients who suffer with anxiety and related disorders
(that is post‐traumatic stress disorder (PTSD), social anxiety disorder (SAnD), panic disorder …

Pellagra and alcoholism: a biochemical perspective

AAB Badawy - Alcohol and Alcoholism, 2014 - academic.oup.com
Historical and clinical aspects of pellagra and its relationship to alcoholism are reviewed
from a biochemical perspective. Pellagra is caused by deficiency of niacin (nicotinic acid) …

[PDF][PDF] Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines

DJ Stein, J Ipser, N McAnda - Cns spectr, 2009 - researchgate.net
Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment
guidelines Page 25 Pharmacotherapy of Posttraumatic Stress Disorder: A Review of MetaAnalyses …

Antidepressants versus placebo for panic disorder in adults

I Bighelli, M Castellazzi, A Cipriani… - Cochrane Database …, 2018 - cochranelibrary.com
Background Panic disorder is characterised by repeated, unexpected panic attacks, which
represent a discrete period of fear or anxiety that has a rapid onset, reaches a peak within …

Trends in the prescription of drugs used for insomnia: an open-cohort study in Australian general practice, 2011–2018

M Begum, D Gonzalez-Chica, C Bernardo… - British Journal of …, 2021 - bjgp.org
Background Despite an increase in the prevalence of sleep problems, few studies have
investigated changes in the prescribing of drugs that are often used to manage insomnia …

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

DJ Stein, E Wreford Andersen, B Tonnoir… - … medical research and …, 2007 - Taylor & Francis
Objective: A randomized, placebo-controlled fixed-dose trial was undertaken to determine
the efficacy and tolerability of escitalopram in obsessive–compulsive disorder (OCD), using …

Understanding the pharmacokinetics of anxiolytic drugs

AC Altamura, D Moliterno, S Paletta… - Expert opinion on …, 2013 - Taylor & Francis
Introduction: Anxiety disorders are considered the most common mental disorders and they
can increase the risk for comorbid mood and substance use disorders, significantly …

Pharmacological treatment for generalized anxiety disorder in adults: an update

JA Reinhold, K Rickels - Expert opinion on pharmacotherapy, 2015 - Taylor & Francis
Introduction: Modest response and remission rates for the selective serotonin reuptake
inhibitors and the serotonin-norepinephrine reuptake inhibitors, coupled with mounting …

Posttraumatic stress disorder and stress-related disorders

AY Shalev - Psychiatric Clinics, 2009 - psych.theclinics.com
Numerous studies have established the frequent occurrence of posttraumatic stress disorder
(PTSD) among individuals exposed to traumas including wars, disasters, terrorist attacks …